Industry

DUBLIN–(BUSINESS WIRE)–The “Validation of FDA-Regulated Systems Used in Drug Development & Submissions Using Artificial Intelligence (AI), Machine Learning (ML) & Large Language Models (LLMs), such as ChatGPT (August 28, 2025)” training has been added to ResearchAndMarkets.com’s offering. Providing safe and effective drugs and other FDA-regulated products is in the best interests of all those involved … [Read more…]

Physician-led company to use its AI-driven solution to bring speed, transparency and clinical expertise to reduce unnecessary care and increase patient safety WINTER PARK, Fla.–(BUSINESS WIRE)–Humata Health, the leader in AI-powered prior authorization technology, has been selected by the Centers for Medicare & Medicaid (CMS) as a key partner for its WISeR model, an initiative … [Read more…]

MURFREESBORO, Tenn.–(BUSINESS WIRE)–National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended September 30, 2025 totaled $382,661,000 compared to $340,198,000 for the quarter ended September 30, 2024, an increase of 12.5%. The increase in net operating revenues for the third quarter … [Read more…]

SHANGHAI–(BUSINESS WIRE)–Yesterday, during the 8th China International Import Expo (“CIIE”), Evinova, a global health-tech company accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, and Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, … [Read more…]

New RAMQ coverage means eligible Québec residents with type 2 diabetes on intensive insulin therapy can now access Dexcom Continuous Glucose Monitoring (CGM) to simplify diabetes management. MONTREAL–(BUSINESS WIRE)–Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Québec government for its recent decision to expand coverage of Dexcom Continuous Glucose Monitoring (CGM) … [Read more…]

PALO ALTO, Calif.–(BUSINESS WIRE)–$GH–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 21, 2025, the Compensation Committee of Guardant’s Board of Directors approved the granting of restricted stock units (“RSUs”) representing 184,961 shares of its common stock to 272 new non-executive employees and one non-qualified stock option award to … [Read more…]

Pivotal Phase 2 trial of RP-A501 for Danon disease to resume in 1H 2026 KRESLADI™ for severe LAD-I on track for March 28, 2026 PDUFA date Leadership updates with the appointments of Dr. Syed Rizvi, Chief Medical Officer, Christopher Stevens, Chief Operating Officer, and Sarbani Chaudhuri, Chief Commercial & Medical Affairs Officer Cash, cash equivalents … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–#SITC–Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial multi-omics data at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting on November 7-10, 2025 in National Harbor, Maryland. The company will showcase how researchers can generate a combination of … [Read more…]

Clinisys expands laboratory innovation with the launch of CLS v2025.2, delivering breakthrough healthcare capabilities with tailored solutions for Clinical Pathology and Genomics labs in North America, and introducing CLS CARE, an AI-powered support agent. TUCSON, Ariz.–(BUSINESS WIRE)–Clinisys is now enhancing its August 2025 release of Clinisys™ Laboratory Solution (CLS) v2025.1—which delivered significant advancements such as … [Read more…]

Continued strong commercial performance and unprecedented pipeline delivery in the year to date CAMBRIDGE, England–(BUSINESS WIRE)–AstraZeneca: Revenue and EPS summary   9M 2025 % Change Q3 2025 % Change   $m Actual CER1 $m Actual CER – Product Sales 41,035 9   9   14,365 11   9   – Alliance Revenue 2,108 41   … [Read more…]